Clark Estates Inc’s AMAG Pharmaceuticals AMAG Stock Holding History

Clark Estates Inc’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-165,000	Closed	-$2.51M	–	99
2018 Q4	$2.51M	Hold	165,000	–	–	0.4%	78
2018 Q3	$3.3M	Sell	165,000 -80,000	-33%	-$1.82M	0.5%	70
2018 Q2	$4.78M	Hold	245,000	–	–	0.71%	26
2018 Q1	$4.94M	Buy	+245,000	New	+$4.14M	0.79%	21
2017 Q4	–	Sell	-163,300	Closed	-$3.01M	–	95
2017 Q3	$3.01M	Buy	163,300 +13,200	+9%	+$246K	0.5%	67
2017 Q2	$2.76M	Buy	150,100 +30,000	+25%	+$594K	0.47%	69
2017 Q1	$2.71M	Buy	120,100 +17,000	+16%	+$407K	0.42%	62
2016 Q4	$3.59M	Hold	103,100	–	–	0.6%	34
2016 Q3	$2.53M	Buy	103,100 +15,000	+17%	+$375K	0.49%	67
2016 Q2	$2.11M	Hold	88,100	–	–	0.42%	80
2016 Q1	$2.06M	Buy	+88,100	New	+$2.09M	0.39%	79

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Clark Estates Inc's AMAG Position: Q1 2019 in Review

Clark Estates Inc sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 165,000 shares — an estimated $2.51M sold.

Clark Estates Inc first reported a position in AMAG in Q1 2016 and held it in 11 quarters. The position peaked at $4.94M in Q1 2018. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Clark Estates Inc reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Clark Estates Inc sold 165,000 AMAG Pharmaceuticals shares in Q1 2019, an estimated $2.51M.
Clark Estates Inc first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 11 quarters.
Clark Estates Inc's AMAG Pharmaceuticals position peaked at $4.94M in Q1 2018.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Clark Estates Inc's 13F filing for Q1 2019, filed 9 May 2019.